After Seven Years Device Tax Repeal Looks Certain

 
• By Ferdous Al-Faruque
  
Generate a summary of this article
Listen to this article
Beta

US lawmakers have agreed on a bipartisan budget to prevent a government shutdown that includes repealing the medical device tax. If all goes according to plan, the bill -- which was approved by the House on 17 December and is now headed to the Senate -- is expected to be on the president’s desk for signing by the end of the week.

United States Capitol on 50 Dollars bill USA money banknote

Almost seven years after it went into effect, the medical device excise tax that has haunted the medtech industry is close to an end. US lawmakers released a last-minute budget agreement to avoid a potential government shutdown that includes a full repeal of the tax and has a high likelihood of passing. By mid-day on 19 December, the consolidated Appropriations bill containing the device tax repeal provision was approved by the US House of Representatives and the Senate, and was headed to President's desk to be signed.

House Speaker Nancy Pelosi, D-CA, and Senate Majority Leader Mitch McConnell, R-KY, have come to an agreement over a $1.3tn...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from Legislation

MI-PolicyAndRegulation (Free-1): Biliary Atresia Linked to Autism and Neurodevelopment Delays

 
• By Nabil

Children with biliary atresia (BA) exhibited neurodevelopmental deficits and increased autism traits, with earlier surgery linked to better general neurodevelopment.

Better Coverage For Cancer Screening Tests On Horizon

 
• By Elizabeth Orr

Multi-cancer diagnostics can help get oncology patients the treatment they need more quickly, but lack of reimbursement has kept such tests out of reach for many patients. Bills providing coverage have passed or are under consideration in more than half of the states and have been introduced in both houses of US Congress.

FDA To Expand Postmarket Surveillance Of Medical Devices, Per GAO Report Requested By Lawmakers

 
• By Brian Bossetta

A government report requested by US lawmakers Debbie Dingell and Anna Eshoo to review the FDA’s postmarket surveillance of medical devices stresses that strengthening the system is critical to addressing adverse events linked to devices after they hit the market.

Legislation Could Bring Good News To Medicare Recipients With Severe Hearing Loss

 
• By Brian Bossetta

A bipartisan bill now in the US Senate seeks to change the classification of implantable hearing aid devices to allow Medicare to reimburse for the devices, potentially expanding access for many Americans who require them.

More from Policy & Regulation

News We’re Watching: New FDA Approvals For Breast Implant, Colon Cancer Test, Imaging Agent; TAP Expansion, AI Standards

This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.  

MI-PolicyAndRegulation (Free-1): Biliary Atresia Linked to Autism and Neurodevelopment Delays

 
• By Nabil

Children with biliary atresia (BA) exhibited neurodevelopmental deficits and increased autism traits, with earlier surgery linked to better general neurodevelopment.

Sponsored By

Nancy Tests SPARC-931 Part 7

This is a description